Rasalkar D. Dattatray

发表

Intermittent versus continuous erlotinib with concomitant modified “XELOX” (q3W) in first‐line treatment of metastatic colorectal cancer

A. King, A. Ahuja, E. Hui, 2013, Cancer.

Intermittent Versus Continuous Erlotinib With Concomitant Modified “ XELOX ” ( q 3 W ) in First-Line Treatment of Metastatic Colorectal Cancer Correlation With Serum Amphiregulin and Transforming Growth Factor Alpha

A. King, A. Ahuja, E. Hui, 2013 .